Moza 15mg Tablet SR

Introduction

Moza is a prescription medication that contains the active ingredient Mosapride. It is available in tablet form and is commonly prescribed under the brand name Moza.

Uses

Moza is primarily used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD). It helps to relieve symptoms such as heartburn, regurgitation, and stomach discomfort caused by the excessive production of stomach acid.

Dosage and Administration

• The recommended dosage of Moza is determined by your healthcare provider based on your specific medical condition.
• It is typically taken orally, with or without food.
• Swallow the tablet whole with a glass of water, without chewing or crushing it.
• Follow the instructions provided by your healthcare provider or the instructions on the product label.

Mechanism of Action

Mosapride, the active ingredient in Moza, works by increasing the movement of food through the gastrointestinal tract. It acts as a prokinetic agent, enhancing the contractions of the muscles in the stomach and intestines. This helps to improve the flow of food and reduces symptoms such as acid reflux and bloating.

Side Effects

Common side effects include:

• Nausea
• Diarrhea
• Abdominal pain
• Headache
• Dizziness

If any of these side effects persist or worsen, contact your healthcare provider for further guidance.

Serious side effects are rare but may include:

• Allergic reactions such as rash, itching, or swelling
• Difficulty breathing or swallowing
• Chest pain or tightness
• Irregular heartbeat

If you experience any of these serious side effects, seek immediate medical attention.

Drug Interactions

Moza may interact with other medications, including:

• Antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
• Antiarrhythmic medications such as amiodarone and procainamide
• Antipsychotic medications such as haloperidol and risperidone

inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins, to avoid potential interactions.

Precautions

Before taking Moza, consider the following precautions:

• Inform your healthcare provider about any known allergies to Mosapride or any other medications.
• Discuss your medical history, especially if you have a history of heart disease, kidney problems, or liver disease.
• Inform your healthcare provider about all the medications you are currently taking to avoid potential drug interactions.
• Moza may cause drowsiness or dizziness, so avoid activities that require mental alertness until you know how the medication affects you.

Storage

Patient Tips

• Take Moza exactly as prescribed by your healthcare provider.
• If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Avoid consuming alcohol while taking Moza, as it may increase the risk of side effects.
• If you have any concerns or questions about your medication, consult your healthcare provider for clarification.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Mosapride (International database) (Drugs.com) [Accessed 19 Jun. 2024] (online) Available at:
• Hong SW, Shin HW. Mosapride-Induced Movement Disorders. J Mov Disord. 2022 Sep;15(3):273-276. doi: 10.14802/jmd.21149. Epub 2022 May 10. [Accessed 14 Jun. 2024] Available at:
• Yoshida N. [Pharmacological effects of the gastroprokinetic agent mosapride citrate]. Nihon Yakurigaku Zasshi. 1999 May;113(5):299-307. doi: 10.1254/fpj.113.299. [Accessed 16 Jun. 2024] Available at:
• Liu Q, Feng CC, Wang EM, Yan XJ, Chen SL. Efficacy of mosapride plus proton pump inhibitors for treatment of gastroesophageal reflux disease: a systematic review. World J Gastroenterol. 2013 Dec 21;19(47):9111-8. doi: 10.3748/wjg.v19.i47.9111. [Accessed 19 Jun. 2024] Available at: